New Key Statistics Module, Z-Score and F-Score
XKAZ:MRNA_KZ Key Ratios
| Market Cap $ M | 13,260.82 |
| Enterprise Value $ M | 7,748.82 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.13 |
| Price/Sales | 2.70 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 5,056.00 |
| EPS (TTM) $ | -5.82 |
| Beneish M-Score | -2.41 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.33 |
| EV-to-EBITDA | -3.88 |
| PEG | -- |
| Shares Outstanding M | 384.82 |
| Net Margin (%) | -43.99 |
| Operating Margin % | -53.26 |
| Pre-tax Margin (%) | -46.54 |
| Quick Ratio | 4.20 |
| Current Ratio | 4.39 |
| ROA % (ttm) | -12.92 |
| ROE % (ttm) | -17.44 |
| ROIC % (ttm) | -28.85 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.48 |
XKAZ:MRNA_KZ Number of Guru Trades
XKAZ:MRNA_KZ Volume of Guru Trades
Gurus Latest Trades with XKAZ:MRNA_KZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XKAZ:MRNA_KZ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers